Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Ermani

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Journal of Alzheimer'S Disease : JAD|December 5, 2012
Accuracy of diagnostic criteria for sporadic creutzfeldt-jakob disease among rapidly progressive dementiaMatteo Tagliapietra, Gianluigi Zanusso, Michele Fiorini, et al.
Psychiatry Research|September 7, 2010
Reduced right posterior hippocampal volume in women with recurrent familial pure depressive disorderFrancesco Nifosì, Tommaso Toffanin, Halima Follador, et al.
Cancer|June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation statusAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Journal of the Peripheral Nervous System : JPNS|March 26, 2013
Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective studyChiara Briani, Chiara Dalla Torre, Marta Campagnolo, et al.
Cancer|January 28, 2003
A prospective study on glioblastoma in the elderlyAlba A Brandes, Francesca Vastola, Umberto Basso, et al.
Neuro-Oncology|May 26, 2006
Survival following adjuvant PCV or temozolomide for anaplastic astrocytomaAlba A Brandes, Linda Nicolardi, Alicia Tosoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, Alicia Tosoni, Umberto Basso, et al.
Oncotarget|July 14, 2016
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastomaSalveena Schiffgens, Ludwig Wilkens, Alba A Brandes, et al.
Plos One|June 10, 2016
Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI StudyRaffaella Colombatti, Marta Lucchetta, Maria Montanaro, et al.
The Journal of Pathology|March 21, 2012
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscleLuisa Piva, Bruno F Gavassini, Luca Bello, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Journal of Alzheimer'S Disease : JAD|December 5, 2012
Accuracy of diagnostic criteria for sporadic creutzfeldt-jakob disease among rapidly progressive dementiaMatteo Tagliapietra, Gianluigi Zanusso, Michele Fiorini, et al.
Psychiatry Research|September 7, 2010
Reduced right posterior hippocampal volume in women with recurrent familial pure depressive disorderFrancesco Nifosì, Tommaso Toffanin, Halima Follador, et al.
Cancer|June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation statusAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.
Journal of the Peripheral Nervous System : JPNS|March 26, 2013
Lenalidomide in patients with chemotherapy-induced polyneuropathy and relapsed or refractory multiple myeloma: results from a single-centre prospective studyChiara Briani, Chiara Dalla Torre, Marta Campagnolo, et al.
Cancer|January 28, 2003
A prospective study on glioblastoma in the elderlyAlba A Brandes, Francesca Vastola, Umberto Basso, et al.
Neuro-Oncology|May 26, 2006
Survival following adjuvant PCV or temozolomide for anaplastic astrocytomaAlba A Brandes, Linda Nicolardi, Alicia Tosoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, Alicia Tosoni, Umberto Basso, et al.
Oncotarget|July 14, 2016
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastomaSalveena Schiffgens, Ludwig Wilkens, Alba A Brandes, et al.
Plos One|June 10, 2016
Cognition and the Default Mode Network in Children with Sickle Cell Disease: A Resting State Functional MRI StudyRaffaella Colombatti, Marta Lucchetta, Maria Montanaro, et al.
The Journal of Pathology|March 21, 2012
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscleLuisa Piva, Bruno F Gavassini, Luca Bello, et al.
Pageof 13